{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T19:30:36Z","timestamp":1792524636103,"version":"4.5.0"},"reference-count":25,"publisher":"SAGE Publications","issue":"3","license":[{"start":{"date-parts":[[2022,5,31]],"date-time":"2022-05-31T00:00:00Z","timestamp":1653955200000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAD"],"published-print":{"date-parts":[[2022,5,31]]},"abstract":"<jats:p>Background: Alzheimer\u2019s disease (AD) is the most common cause of dementia in the elderly population. However, epidemiological studies on the demographics of AD in Hong Kong population are lacking. Objective: We investigated the demographics, comorbidities, mortality rates, and medication use of patients with AD in Hong Kong to understand how the disease has been managed locally. Methods: This was a collaborative study of The Hong Kong University of Science and Technology and the Hospital Authority Data Collaboration Lab. We analyzed the demographic data, clinical records, diagnoses, and medication records of patients with AD under the care of the Hospital Authority between January 1, 2007 and December 31, 2017. Results: We identified 23,467 patients diagnosed with AD. The median age at diagnosis was 84 years old, and 71% of patients were female. The most common comorbidity was hypertension (52.6%). 39.9% of patients received medications for dementia; of those, 68.4% had taken those medications for &gt;\u200a1 year. Compared to nonusers, long-term AD medication users had a significantly younger age of AD onset and were taking more lipid-regulating medication, diabetes medication, or antidepressants. Surprisingly, the use of antipsychotics in patients with AD was quite common; 50.7% of patients had received any type of antipsychotic during disease progression. Conclusion: This study provides detailed information on the demographics and medication use of patients with AD in Hong Kong. The data from this AD cohort will aid our future research aiming to identify potential AD risk factors and associations between AD and other diseases.<\/jats:p>","DOI":"10.3233\/jad-215312","type":"journal-article","created":{"date-parts":[[2022,4,19]],"date-time":"2022-04-19T12:09:42Z","timestamp":1650370182000},"page":"1205-1213","source":"Crossref","is-referenced-by-count":10,"title":["Demographics and Medication Use of Patients with Late-Onset Alzheimer\u2019s Disease in Hong Kong"],"prefix":"10.1177","volume":"87","author":[{"given":"Hiu Yi","family":"Wong","sequence":"first","affiliation":[{"name":"Division of Life Science, State Key Laboratory of Molecular Neuroscience, Molecular Neuroscience Center, The Hong Kong University of Science and Technology, Clear Water Bay, Hong Kong, China"},{"name":"Hong Kong Center for Neurodegenerative Diseases, Hong Kong Science Park Hong Kong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huan","family":"Zhong","sequence":"additional","affiliation":[{"name":"Division of Life Science, State Key Laboratory of Molecular Neuroscience, Molecular Neuroscience Center, The Hong Kong University of Science and Technology, Clear Water Bay, Hong Kong, China"},{"name":"Hong Kong Center for Neurodegenerative Diseases, Hong Kong Science Park Hong Kong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingqian","family":"Zhong","sequence":"additional","affiliation":[{"name":"Division of Life Science, State Key Laboratory of Molecular Neuroscience, Molecular Neuroscience Center, The Hong Kong University of Science and Technology, Clear Water Bay, Hong Kong, China"},{"name":"Hong Kong Center for Neurodegenerative Diseases, Hong Kong Science Park Hong Kong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaopu","family":"Zhou","sequence":"additional","affiliation":[{"name":"Division of Life Science, State Key Laboratory of Molecular Neuroscience, Molecular Neuroscience Center, The Hong Kong University of Science and Technology, Clear Water Bay, Hong Kong, China"},{"name":"Hong Kong Center for Neurodegenerative Diseases, Hong Kong Science Park Hong Kong, China"},{"name":"Guangdong Provincial Key Laboratory of Brain Science, Disease and Drug Development, HKUST Shenzhen Research Institute, Shenzhen\u2013Hong Kong Institute of Brain Science, Shenzhen, Guangdong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phillip Y.C.","family":"Chan","sequence":"additional","affiliation":[{"name":"Division of Life Science, State Key Laboratory of Molecular Neuroscience, Molecular Neuroscience Center, The Hong Kong University of Science and Technology, Clear Water Bay, Hong Kong, China"},{"name":"Hong Kong Center for Neurodegenerative Diseases, Hong Kong Science Park Hong Kong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy C.Y.","family":"Kwok","sequence":"additional","affiliation":[{"name":"Therese Pei Fong Chow Research Centre for Prevention of Dementia, Division of Geriatrics, Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Shatin, Hong Kong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kin","family":"Mok","sequence":"additional","affiliation":[{"name":"Division of Life Science, State Key Laboratory of Molecular Neuroscience, Molecular Neuroscience Center, The Hong Kong University of Science and Technology, Clear Water Bay, Hong Kong, China"},{"name":"Hong Kong Center for Neurodegenerative Diseases, Hong Kong Science Park Hong Kong, China"},{"name":"Department of Neurodegenerative Disease, UCL Institute of Neurology, London, UK"},{"name":"UK Dementia Research Institute at UCL, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Hardy","sequence":"additional","affiliation":[{"name":"Hong Kong Center for Neurodegenerative Diseases, Hong Kong Science Park Hong Kong, China"},{"name":"Department of Neurodegenerative Disease, UCL Institute of Neurology, London, UK"},{"name":"UK Dementia Research Institute at UCL, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fanny C.F.","family":"Ip","sequence":"additional","affiliation":[{"name":"Division of Life Science, State Key Laboratory of Molecular Neuroscience, Molecular Neuroscience Center, The Hong Kong University of Science and Technology, Clear Water Bay, Hong Kong, China"},{"name":"Hong Kong Center for Neurodegenerative Diseases, Hong Kong Science Park Hong Kong, China"},{"name":"Guangdong Provincial Key Laboratory of Brain Science, Disease and Drug Development, HKUST Shenzhen Research Institute, Shenzhen\u2013Hong Kong Institute of Brain Science, Shenzhen, Guangdong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy K.Y.","family":"Fu","sequence":"additional","affiliation":[{"name":"Division of Life Science, State Key Laboratory of Molecular Neuroscience, Molecular Neuroscience Center, The Hong Kong University of Science and Technology, Clear Water Bay, Hong Kong, China"},{"name":"Hong Kong Center for Neurodegenerative Diseases, Hong Kong Science Park Hong Kong, China"},{"name":"Guangdong Provincial Key Laboratory of Brain Science, Disease and Drug Development, HKUST Shenzhen Research Institute, Shenzhen\u2013Hong Kong Institute of Brain Science, Shenzhen, Guangdong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nancy Y.","family":"Ip","sequence":"additional","affiliation":[{"name":"Division of Life Science, State Key Laboratory of Molecular Neuroscience, Molecular Neuroscience Center, The Hong Kong University of Science and Technology, Clear Water Bay, Hong Kong, China"},{"name":"Hong Kong Center for Neurodegenerative Diseases, Hong Kong Science Park Hong Kong, China"},{"name":"Guangdong Provincial Key Laboratory of Brain Science, Disease and Drug Development, HKUST Shenzhen Research Institute, Shenzhen\u2013Hong Kong Institute of Brain Science, Shenzhen, Guangdong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","reference":[{"key":"10.3233\/JAD-215312_ref1","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1016\/S0140-6736(10)61349-9","article-title":"Alzheimer\u2019s disease","volume":"377","author":"Ballard","year":"2011","journal-title":"Lancet"},{"key":"10.3233\/JAD-215312_ref2","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.jalz.2017.12.006","article-title":"The cost of Alzheimer\u2019s disease in China and re-estimation of costs worldwide","volume":"14","author":"Jia","year":"2018","journal-title":"Alzheimers Dement"},{"key":"10.3233\/JAD-215312_ref3","unstructured":"Population By-census Thematic Report: Older Persons. Census and Statistics Department, Hong Kong Special Administrative Region."},{"key":"10.3233\/JAD-215312_ref4","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1093\/ije\/dyy007","article-title":"Prevalence of dementia in mainland China, Hong Kong and Taiwan: An updated systematic review and meta-analysis","volume":"47","author":"Wu","year":"2018","journal-title":"Int J Epidemiol"},{"key":"10.3233\/JAD-215312_ref5","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1212\/WNL.50.4.1002","article-title":"Prevalence of dementia in Chinese elderly in Hong Kong","volume":"50","author":"Chiu","year":"1998","journal-title":"Neurology"},{"key":"10.3233\/JAD-215312_ref6","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1017\/S1041610207006199","article-title":"Prevalence of very mild and mild dementia in community-dwelling older Chinese people in Hong Kong","volume":"20","author":"Lam","year":"2008","journal-title":"Int Psychogeriatr"},{"key":"10.3233\/JAD-215312_ref7","unstructured":"Hospital Authority Statistical Report 2016-2017. Hospital Authority, Hong Kong Special Administrative Region."},{"key":"10.3233\/JAD-215312_ref8","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1080\/13607863.2013.768211","article-title":"Residents with Alzheimer\u2019s disease in long-term care facilities in Hong Kong: Patterns of hospitalization and emergency room use","volume":"17","author":"Leung","year":"2013","journal-title":"Aging Ment Health"},{"key":"10.3233\/JAD-215312_ref9","doi-asserted-by":"crossref","first-page":"193","DOI":"10.3233\/JAD-140174","article-title":"Characteristics of Alzheimer\u2019s disease among patients in Taiwan, Hong Kong, and Beijing","volume":"42","author":"Yang","year":"2014","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-215312_ref10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jalz.2013.01.012","article-title":"The prevalence of dementia in urban and rural areas of China","volume":"10","author":"Jia","year":"2014","journal-title":"Alzheimers Dement"},{"key":"10.3233\/JAD-215312_ref11","doi-asserted-by":"crossref","first-page":"387","DOI":"10.2147\/CEOR.S93323","article-title":"The epidemiology and burden of Alzheimer\u2019s disease in Taiwan utilizing data from the National Health Insurance Research Database","volume":"8","author":"Hung","year":"2016","journal-title":"Clinicoecon Outcomes Res"},{"key":"10.3233\/JAD-215312_ref12","doi-asserted-by":"crossref","first-page":"565","DOI":"10.3233\/JAD-121819","article-title":"Epidemiology, co-morbidities, and medication use of patients with Alzheimer\u2019s disease or vascular dementia in the UK","volume":"35","author":"Imfeld","year":"2013","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-215312_ref13","doi-asserted-by":"crossref","unstructured":"(2020) 2020 Alzheimer\u2019s disease facts and figures. Alzheimers Dement 16, 391\u2013460.","DOI":"10.1002\/alz.12068"},{"key":"10.3233\/JAD-215312_ref14","doi-asserted-by":"crossref","first-page":"128","DOI":"10.3390\/ijerph16010128","article-title":"Perceptions of Chinese towards dementia in Hong Kong-diagnosis, symptoms and impacts","volume":"16","author":"Lam","year":"2019","journal-title":"Int J Environ Res Public Health"},{"key":"10.3233\/JAD-215312_ref15","first-page":"e12074","article-title":"Genetic and polygenic risk score analysis for Alzheimer\u2019s disease in the Chinese population","volume":"12","author":"Zhou","year":"2020","journal-title":"Alzheimers Dement (Amst)"},{"key":"10.3233\/JAD-215312_ref16","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1111\/ene.13302","article-title":"Trends of mortality from Alzheimer\u2019s disease in the European Union, 1994-2013","volume":"24","author":"Niu","year":"2017","journal-title":"Eur J Neurol"},{"key":"10.3233\/JAD-215312_ref17","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1080\/14737167.2020.1820328","article-title":"Hospital incidence, mortality and costs of Alzheimer\u2019s disease in Spain:Aretrospective multicenter study","volume":"21","author":"Darb\u00e0","year":"2021","journal-title":"Expert Rev Pharmacoecon Outcomes Res"},{"key":"10.3233\/JAD-215312_ref18","doi-asserted-by":"crossref","first-page":"e0213825","DOI":"10.1371\/journal.pone.0213825","article-title":"Pneumonia-associated death in patients with dementia: A systematic review and meta-analysis","volume":"14","author":"Manabe","year":"2019","journal-title":"PLoS One"},{"key":"10.3233\/JAD-215312_ref19","doi-asserted-by":"crossref","first-page":"101174","DOI":"10.1016\/j.arr.2020.101174","article-title":"A research agenda for ageing in China in the 21st century (2nd edition): Focusing on basic and translational research, long-term care, policy and social networks","volume":"64","author":"Fang","year":"2020","journal-title":"Ageing Res Rev"},{"key":"10.3233\/JAD-215312_ref20","doi-asserted-by":"crossref","first-page":"773","DOI":"10.3233\/JAD-170786","article-title":"Medical comorbidity in Alzheimer\u2019s disease: A nested case-control study","volume":"63","author":"Wang","year":"2018","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-215312_ref21","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/alzrt264","article-title":"Cardiovascular medication burden in dementia disorders: A nationwide study of 19,743 dementia patients in the Swedish Dementia Registry","volume":"6","author":"Cermakova","year":"2014","journal-title":"Alzheimers Res Ther"},{"key":"10.3233\/JAD-215312_ref22","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.jep.2014.12.015","article-title":"Demographic and medication characteristics of traditional Chinese medicine users among dementia patients in Taiwan: A nationwide database study","volume":"161","author":"Lin","year":"2015","journal-title":"J Ethnopharmacol"},{"key":"10.3233\/JAD-215312_ref23","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1016\/j.jagp.2013.01.041","article-title":"Neuropsychiatric symptom clusters of Alzheimer disease in Hong Kong Chinese: Correlates with caregiver burden and depression","volume":"21","author":"Cheng","year":"2013","journal-title":"Am J Geriatr Psychiatry"},{"key":"10.3233\/JAD-215312_ref24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s13670-019-0269-1","article-title":"Pharmacologic management of agitation in patients with dementia","volume":"8","author":"McDermott","year":"2019","journal-title":"Curr Geriatr Rep"},{"key":"10.3233\/JAD-215312_ref25","doi-asserted-by":"crossref","first-page":"29","DOI":"10.3390\/geriatrics2030029","article-title":"Systematic review of cholinesterase inhibitors on cognition and behavioral symptoms in patients of Chinese descent with Alzheimer\u2019s disease, vascular dementia, or mixed dementia","volume":"2","author":"Leung","year":"2017","journal-title":"Geriatrics (Basel)"}],"container-title":["Journal of Alzheimer's Disease"],"original-title":[],"link":[{"URL":"https:\/\/content.iospress.com\/download?id=10.3233\/JAD-215312","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T10:05:55Z","timestamp":1777370755000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/full\/10.3233\/JAD-215312"}},"subtitle":[],"editor":[{"given":"Jianping","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2022,5,31]]},"references-count":25,"journal-issue":{"issue":"3"},"URL":"https:\/\/doi.org\/10.3233\/jad-215312","relation":{},"ISSN":["1387-2877","1875-8908"],"issn-type":[{"value":"1387-2877","type":"print"},{"value":"1875-8908","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,31]]}}}